Biotech: Page 38
-
PharmaVoice Team/PharmaVoice
UpFront
High School Students from Canada and Arizona Receive Top Honors in BioGENEius Challenge Winners of the annual International BioGENEius Challenge were announced at the 2015 BIO International Convention in Philadelphia. Anvita Gupta (12th Grade, Scottsdale, Ariz.) received top prize for the Global ...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Who's on the list by Company
AbelsonTaylor Inc. Keith Stenlund Achillion Pharmaceuticals Kevin Kucharski Advanced Clinical LLC Leo Sheridan Alcobra Pharma David Baker Altasciences Chris Perkin AmerisourceBergen Corp. Marc Kikuchi Artcraft Health Marc Sirockman Astellas Pharma US Inc. Jim Robinson Astr...
By PharmaVoice Team • Aug. 1, 2015 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The PharmaVOICE 100 Celebration, to be held Sept. 17, at the Apella Event Space Riverpark Tom Colicchio Restaurant located at The Alexandria Center for Life Science, convenes the most influential and inspirational leaders from across all sectors of the life-sciences industry. P...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma Pool Marcello Agosti Takeda Names Head of New Global Commercial Organization Takeda has named Marcello Agosti head of global commercial, based in Zurich. The company established the global commercial organization as part of its plans to structure operations to become more agile and custome...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
Commanders & Chiefs Dr. Michelle Berrey Chimerix Rob Cosinuke athenahealth and Epocrates Jim Curtis Remedy Health Media Dr. Bruce Feinberg Cardinal Health Specialty Solutions Lisa Giles Giles & Associates Consultancy Inc. and Optivara Inc. Peter Goldschmidt Sandoz Inc. D...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs
Mark Timney Title: President and CEO Company: Purdue Pharma LP Education: Bachelor’s Degree in Sports, majoring in Marketing, Newcastle Polytechnic, (now Northumbria University) Family: Wife, Michelle; son, Aidan, 12 Bucket List: Attend a European Champions League final, in which Liverpool wins A...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Entrepreneurs
Elizabeth Holmes Title: Chairman, CEO, Founder Company: Theranos Education: Honorary doctorate degree, Pepperdine University Awards/Honors: Youngest person to be awarded the Horatio Alger Award; TIME 100 Most Influential People in the World in 2015; Best Health Startup, Crunchies Awards, 2015; T...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Researchers & Scientists
Dr. Anish Suri Title: Senior Scientific Director, Discovery Immunology Company: Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson Education: Ph.D., Immunology, Washington University St. Louis; B.S., Biology, Angelo State University Famil...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Fun Facts About the PharmaVOICE 100
Where they were born? The PharmaVOICE 100 may come from all over, but what they have in common is a sincere desire to improve the lives of patients everywhere. What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it t...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Overcoming the Challenges that Hinder Innovation
PharmaVOICE 100 honorees discuss the challenges that the industry needs to overcome to support future innovation. Between 2009 and 2014, the annual growth rate for the top 25 life-sciences companies slowed from the prior decade’s double-digit average to only 1% annually, according to a recent rep...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Innovation In a Patient-Centric World
From healthcare reform to the push for value in medicines to personalized healthcare, the patient is now at the center of, well, everything. This means that pharmaceutical companies are now required to create a new paradigm, with the patient at the center. An initiative that began last year withi...
By PharmaVoice Team • Aug. 1, 2015 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In the rare disease community there is saying: Alone we are rare, together we are strong. Wendy White, senior VP, for rare diseases, at Dohmen Life Science Services, a board member of Global Genes, and the president of the Heathcare Businesswomen’s Association (HBA), shared her personal rare dis...
By Taren Grom • June 1, 2015 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The annual BIO International Convention, June 15-18, 2015, in Philadelphia covers the wide spectrum of life-sciences innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries repre...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biopharma Pool David Allsop Amicus Therapeutics Appoints Senior VP, International Amicus Therapeutics, a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has appointed David Allsop as senior VP, international. He is responsible for Amicus’ international organi...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biopharma Pool Steven Ertel Dr. Matthew Sherman Acceleron Pharma Announces Executive Appointments and Promotions Acceleron Pharma, a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic candidates that regulate cellular growth...
By PharmaVoice Team • May 1, 2015 -
PharmaVoice Team/PharmaVoice
2015 HBA Luminaries
The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...
By Taren Grom • May 1, 2015 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Venture Funding Trends Trending now: Report shows an increase in funding for rare diseases and a decrease in funding for chronic diseases. Seventy-eight percent of U.S. venture investment for therapeutics went toward novel drug R&D, suggesting innovation is a core priority for venture investo...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotechnology Pool Mary Thistle Dimension Names Chief Business Officer Dimension Therapeutics, a rare disease company advancing novel treatments for diverse genetic disorders of the liver based upon an AAV gene therapy platform, has appointed Mary Thistle to the newly created position of chief bu...
By PharmaVoice Team • April 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotechnology Pool Tony Hunt Repligen Names CEO Repligen, a life-sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs, has appointed Tony Hunt as CEO. Mr. Hunt, currently Repligen’s chief operatin...
By PharmaVoice Team • March 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry Pharma Pool Dr. Julie Gerberding Merck Strengthens Executive Team Merck has named Julie Gerberding, M.D., as executive VP for strategic communications, global public policy and population health. In this newly created executive comm...
By PharmaVoice Team • Feb. 1, 2015 -
PharmaVoice Team/PharmaVoice
Last Word
Addressing the Needs of THOSE WITH RARE DISEASES Peter Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), talks about recent orphan drug approvals. PV: 2014 was a record year for orphan drug approvals. What are your predictions for the orphan drug space for 201...
By Peter Saltonstall • Feb. 1, 2015 -
PharmaVoice Team/PharmaVoice
R&D Crowdsourcing: Crowdsourcing in Pharma
Companies are looking at nontraditional ways of collaborating to access new insights that could lead to innovative therapies. There is a growing movement within the industry toward open access and crowdsourcing scientific information to accelerate research and development. This open environment r...
By Denise Myshko • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: E-Solutions: Power Surge
E-Solutions ranging from mobile advances to EMR technologies are expected to reframe the patient model. Notably, the most encouraging news on mobile and quantified health is the recent announcement and launch of the HealthKit platform and the mobile app Health by Apple. HealthKit allows devices a...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Year in Preview: On the Horizon: Looking Ahead…
Experts from across all sectors of the industry provide their input on the trends in 2015 that will have the biggest impact on the industry, and how they will shape the future of healthcare. For this year’s special Year in Preview issue we took a slightly different tact than in years past. We are...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotech Pool Dr. Annalisa Jenkins Dimension Therapeutics Names CEO Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, has apppointed Annalisa Jenkins, MBBS, MRCP, CEO. Dr. Jenkins succeeds interim CEO Thomas Beck. Dr. Jenkins brings to Dimensi...
By Ann Grey • Nov. 15, 2014
Previous
